
Euclid mission data release is step toward grand atlas of the cosmos
Summary
Euclid was launched in 2023 on a planned six-year mission
Mission is exploring nature of dark energy and dark matter
Data hints at the organization of galaxies in cosmic web
March 19 (Reuters) - The European Space Agency has released its first tranche of data from the Euclid space telescope 's mission to map the universe 's large-scale structure in order to better understand the mysterious cosmic components dark energy and dark matter.
Scientists unveiled on Wednesday Euclid's observations of three patches of the sky populated by a panoply of galaxies. The data covered a survey of the sky equal to more than 300 times the size of the moon as viewed from Earth - a step toward the Euclid mission's goal of fashioning a grand atlas of the cosmos in exquisite detail, spanning more than a third of the sky.
Euclid, launched from Florida in 2023 on a planned six-year mission, is an orbiting observatory gathering data on how the universe has expanded and how its structure has formed over time and amassing information about the nature of dark energy and dark matter and the role of gravity on large scales.
The survey areas disclosed on Wednesday account for only about half a percent of the mission's eventual goal. The data represents just one week of observations including one scan of each of the three regions, but it covers 26 million galaxies up to 10.5 billion light-years away. A light-year is the distance light travels in a year, 5.9 trillion miles (9.5 trillion km).
The Big Bang event roughly 13.8 billion years ago initiated the universe, which has been expanding ever since.
The universe's contents include ordinary matter as well as dark matter and dark energy. Ordinary matter - stars, planets, gas, dust and all the familiar stuff on Earth - represents perhaps 5% of the contents. Dark matter is invisible material that may make up about 27% of the cosmos. Dark energy, an enigmatic component thought to be responsible for the accelerated expansion of the universe, may account for 68%.
The newly released Euclid images hint at the large-scale organization of galaxies in what is known as the cosmic web, essentially the backbone of the universe. In this web, there are concentrations of galaxies with voids of space in between, as if the galaxies were sitting on vast empty bubbles.
The cosmic web's structure offers clues about dark matter and dark energy, according to the researchers.
Astrophysicist Carole Mundell, the European Space Agency's director of science, called Euclid a "dark detective."
"We now understand about 5% of the universe," Mundell said. "The other 95% is dark and is unknown."
Euclid measures the various shapes and the distribution of galaxies with its high-resolution imaging visible instrument, or VIS, while its near-infrared instrument, or NISP, determines galaxy distances and masses. Euclid eventually is expected to obtain images of more than 1.5 billion galaxies.
"It is exploring more distant objects in the universe with a greater amount of sky explored than any survey before for objects so far away," astrophysicist Chris Duffy of Lancaster University in England, one of the scientists involved in the research, said of Euclid.
Duffy's part of the Euclid research focuses upon transient objects - ones that appear only briefly - such as stellar explosions called supernovae seen in the observations.
A first detailed catalog of more than 380,000 galaxies of various shapes and sizes, classified according to features such as spiral arms and central bars as well as traits that indicate a galactic merger, was released on Wednesday.
This represents "the first chunk of what will be the largest-ever catalog of the detailed appearance of galaxies," said University of Toronto astrophysicist Mike Walmsley, one of the Euclid scientists.
Light traveling toward Earth from faraway galaxies is bent and distorted by normal matter and dark matter in the foreground in an effect called gravitational lensing. It is one of the tools used by Euclid to study how dark matter is distributed. Researchers have been sifting through the Euclid data to identify strong gravitational lenses, and have identified about 500 such candidates.
"The invisible dark matter in massive galaxies warps space, bending light rays like a magnifying glass. This magnifies and distorts the galaxies behind them into arcs and rings, and measuring the distortion lets us measure the invisible dark matter. But the galaxies must be very precisely aligned, so this strong lensing effect is very rare," Walmsley said.
"Euclid is the best instrument ever built for finding these, because it can take an exceptionally sharp image of wide patches of sky – while telescopes like Hubble and the James Webb Space Telescope are designed to look at much smaller patches," Walmsley added.
The next Euclid data release, planned for October 2026, will cover an area 30 times larger than Wednesday's release.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


NBC News
a day ago
- NBC News
These cosmic monsters are creating the biggest explosions since the big bang
The vast emptiness of space is growing emptier one star at a time. That's because 80 billion lightyears from Earth, three cosmic beasts are devouring stars ten times the size of the sun. In a new study by the University of Hawaii, among others, astronomers scouring through NASA and European Space Agency's data said they had discovered three supermassive black holes. Those behemoths feast on stars of such a size that make the one at the center of the solar system look like a light snack. The explosions those scientists have recorded, which happened when those black holes shredded and sucked up the fabric of those stars, are the largest since the big bang that created the universe. 'What I think is so exciting about this work is that we're pushing the upper bounds of what we understand to be the most energetic environments of the universe,' Anna Payne, a staff scientist at the Space Telescope Science Institute and a co-author of the study, said in the NASA article. Black holes are astronomical objects invisible to the human eye. They have a gravitational pull so strong that they swallow everything, including light. A supermassive black hole is the biggest of all black holes, sitting at the center of galaxies like the one at the heart of the Milky Way slowly sucking planets and all other matter toward it. When a star gets trapped in the pull of a supermassive black hole, it can disintegrate with a spectacular explosion in a cosmic event that scientists in a new study published this week in the journal Science Advances call 'extreme nuclear transient.' 'These events are the only way we can have a spotlight that we can shine on otherwise inactive massive black holes,' University of Hawaii graduate student Jason Hinkle said in a separate NASA article. Hinkle is the lead author of the new study that describes for the first time two such events that took place over the past decade. Two of the three supermassive black holes were detected in 2016 and 2018 by an ESA mission and are documented for the first time in the study. The third, nicknamed 'Barbie' because of its catalog identifier ZTF20abrbeie, was identified in 2020 by a Caltech observatory in California and subsequently documented in 2023. The blasts are so powerful that the only cosmic event larger in magnitude has been the big bang that sparked the dawn of the universe. Unlike in other stellar explosions, though, the way X-ray, optical light and ultraviolet rays dimmed and brightened in these incidents made it clear this event was a 'black hole ripping a star apart,' the NASA article said. NASA says black holes actually brighten during these cosmic events and that brightness lasts for several months. That brightness has given scientists a new way to find more black holes in the early distant universe. When astronomers peer into space, they are looking back in time because the further away they look, the older the light is reaching them — the light reaching Earth from the sun, for example, is eight minutes old. 'We can take these three objects as a blueprint to know what to look for in the future,' Payne said.


Reuters
a day ago
- Reuters
Health Rounds: Roche's Tecentriq reduces recurrence, deaths for certain colon cancer patients
June 6 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign up here.) Adding Roche's (ROG.S), opens new tab immunotherapy drug Tecentriq to chemotherapy after surgery in certain patients whose colon cancer had spread to the lymph nodes led to a 50% reduction in cancer recurrence and death compared to chemotherapy alone, according to trial data presented at recent medical meeting. Patients in the study had tumors with a genetic defect known as deficient DNA mismatch repair, or dMMR. About 15% of colon cancer patients have dMMR tumors, which do not respond well to chemotherapy. "The findings from our study represent a major advance in the adjuvant treatment of dMMR stage 3 colon cancer and will now change the treatment for this type of cancer," study leader Dr. Frank Sinicrope of the Mayo Clinic in Rochester, Minnesota said in a statement. The data, opens new tab were presented at the ASCO meeting that concluded earlier this week. The trial enrolled 712 patients with dMMR stage 3 colon cancer that had been surgically removed and who had cancer cells in their lymph nodes. Half of the study participants received chemotherapy along with Tecentriq, which activates the immune system to attack and kill cancer cells, for six months, followed by the immunotherapy alone for another six months. The other half of the patients received chemotherapy for 12 months. The benefit of Tecentriq was seen even in the oldest patients and those at particularly high-risk. "It's extremely rewarding to be able to offer our patients a new treatment regimen that can reduce the risk of recurrence and improve their chances of survival," Sinicrope said. As patients recover after a minimally invasive heart procedure, they might be better off continuing to take a certain type of blood-thinning drug to help prevent a heart attack or stroke, instead of continuing with the traditional aspirin, a new study suggests. Early after percutaneous coronary intervention (PCI) - a procedure to prop open blocked arteries either after a heart attack, or to prevent one - patients often receive dual anti-clotting therapy with both a P2Y12 inhibitor such as clopidogrel, the generic version of Plavix, or AstraZeneca's (AZN.L), opens new tab Brilinta (ticagrelor), and aspirin. After several months, patients are usually switched from dual therapy to lifelong daily aspirin use. But pooled data looking at patients who took part in five earlier clinical trials found that continuing to prescribe the P2Y12 inhibitors and stopping the aspirin was associated with lower rates of death, heart attack and stroke compared with continuing the aspirin, with no increased risk of major bleeding, researchers reported in The BMJ, opens new tab. Overall, the trials involved 16,117 patients who received either a P2Y12 inhibitor or aspirin after completing dual therapy following PCI. After an average follow-up period of around 4 years, P2Y12 inhibitor therapy was associated with a 23% lower risk of a composite of heart-related death, heart attack, or stroke, compared with aspirin, with no significant difference in major bleeding. That translates into one prevented cardiovascular death, heart attack, or stroke for every 46 patients taking a P2Y12 inhibitor instead of aspirin after dual therapy. Overall, the findings suggest that P2Y12 inhibitor drugs should be preferred over aspirin 'due to reductions in major adverse cardiac and cerebrovascular events without increasing major bleeding in the medium term,' according to an editorial published with the study. But the editorial said that since patients are advised to continue the post-PCI therapy for life, large trials directly comparing the different strategies with longer follow up are needed. Some diabetes and weight-loss drugs from the class known as GLP-1 agonists were linked with a small but elevated risk for an age-related eye disease in patients with diabetes, according to a study published on Thursday in JAMA Ophthalmology, opens new tab. In 139,000 patients with diabetes, including 46,334 who had been using the GLP-1 drugs semaglutide or lixisenatide, researchers identified 181 new cases of neovascular age-related macular degeneration, also known as wet AMD. Wet AMD is a degenerative eye disease marked by the abnormal growth of blood vessels under the retina that leak fluid or blood and can lead to blindness. The risk of developing AMD during up to three years of follow-up was low, at 0.2% in GLP-1 users versus 0.1% in non-users. Still, the researchers point out, after accounting for patients' individual risk factors, the odds of AMD were doubled with at least six months of GLP-1 use and tripled in patients with the longest duration of use. Semaglutide is the active ingredient in the widely used Novo Nordisk ( opens new tab drugs Ozempic and Wegovy, while lixisenatide is the main ingredient in Sanofi's ( opens new tab discontinued Adlyxin. GLP-1 drugs have also been associated with higher risks for an eye condition known as nonarteritic anterior ischemic optic neuropathy, or NAION. Researchers did not have information about the dose, route of administration, or frequency of administration of the medications used in the study. Even with that information, the study could not have proved cause and effect. At least one earlier study with longer follow up reported that GLP-1 use was linked with a lower, rather than higher, risk for AMD. 'Our findings are not directly contradictory' with that earlier report, said study leader Dr. Reut Shor of the University of Toronto. 'Factors such as timing and duration of exposure, disease stage, and patient characteristics may all influence outcomes," Shor said. "Our results add another layer to the emerging understanding of this complex relationship and emphasize the need for further research to clarify these trends.' (To receive the full newsletter in your inbox for free sign up here)


Reuters
2 days ago
- Reuters
Artificial Intelligence is now an A+ law student, study finds
June 5 (Reuters) - The latest generation of generative artificial intelligence can ace most law school final exams, a new study has found. OpenAI's newest model, called o3, earned grades ranging from A+ to B on eight spring finals given by faculty at the University of Maryland Francis King Carey School of Law, researchers found in a new paper published on SSRN, opens new tab. Those high grades represent a significant improvement from previous studies done on earlier versions of ChatGPT, also from OpenAI, which scored B's, C's, and even one D's when researchers had them take law school finals in 2022 and 2023, according to the paper. Studies conducted earlier by other researchers had also found that ChatGPT earned 'mediocre' grades on law school finals and that although it improved the speed of legal writing, it did not improve the quality. Researchers also have found that AI can pass the bar exam. However, generative AI looks to be catching up to actual high-performing law students, based on the latest study. Unlike ChatGPT, which immediately generates text in response to a user's query, o3 is what is known as a reasoning model. This means that it generates tentative answers and multiple approaches to questions after internally evaluating and revising those responses, after which it produces the final text for the user. The study's authors — seven law professors from University of Maryland — graded the final answers from o3 on the same curve they use for their students. The program's answers earned an A+ in Constitutional Law, Professional Responsibility, and Property. Its answers got an A in Income Taxation, and an A- in Criminal Procedure. It scored a B+ in Secured Transactions and Torts, and a B in Administrative Law. The's answers program did well on both multiple choice questions and essays, the study found. However, there were some limitations on o3's answers. The program's relatively low grade in administrative law was attributable to the fact that o3 did not know about the 2024 U.S. Supreme Court opinion in Loper Bright Enterprises v. Raimondo, which overturned the Chevron doctrine, which was central to administrative law. That ruling had come shortly after the o3's knowledge cutoff date. The o3 program performed worse on one final when given access to the professor's notes — an unanticipated outcome the researchers attributed to the program being 'distracted' by too much text. OpenAI did not immediately respond to a request for comment on Thursday about the study's findings. The study's authors wrote that they are already contemplating an updated experiment to determine how much of a cheating threat AI poses by instructing the program to make occasional spelling and grammar mistakes, so that those exams will be difficult to distinguish from those completed by real students. Read more: ChatGPT passes law school exams despite 'mediocre' performance AI improves legal writing speed, not quality - study